Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
HDA Statement on FDA’s Phased Exemption for Eligible Trading Partners from the DSCSA’s Final Implementation Requirements
HDA released a statement from President and CEO Chester “Chip” Davis, Jr., on the Food and Drug Administration’s (FDA) issuing of an exemption for eligible trading partners to comply with the final requirements of the Drug Supply Chain Security Act (DSCSA).
HDA Statement on Senate Confirmation of Dr. Robert Califf as FDA Commissioner
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement upon the U.S. Senate’s vote to confirm Dr. Robert Califf as FDA Commissioner.
HDA To Host Traceability Seminar in August
The Healthcare Distribution Alliance (HDA) will host its annual Traceability Seminar two months early, on August 29–31, 2023, in Washington, D.C. The earlier date reflects the urgency surrounding the upcoming Drug Supply Chain Security Act (DSCSA) implementation deadline and the critical need to share information and solutions.
Kaminsky and Hatcher To Lead HDA Board of Directors; Syvinski Appointed to Executive Committee
The Healthcare Distribution Alliance (HDA) announced Kirk Kaminsky and Jody Hatcher will serve a second year as Chairman and Vice Chairman, respectively, of the HDA Board of Directors.